Epstein Secrets

. The New York Post <https://nypost.corn/2020/07/30/johnson-johnson-starts-human-vaccine-trials-after-monkey- study/> (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmaker

h investigations of 113." The report "showed that amid a deterioration in US-China ties, the number of deals involving Chinese companies reviewed by CFIUS dropped from 60 in 2017 to 55 in 2018 and 25 last year." In eight cases, CFIUS "told the parties to the transactions that they could not identify a

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

investigations of 113." The report "showed that amid a deterioration in US-China ties, the number of deals involving Chinese companies reviewed by CFIUS dropped from 60 in 2017 to 55 in 2018 and 25 last year." In eight cases, CFIUS "told the parties to the transactions that they could not identify a

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

investigations of 113." The report "showed that amid a deterioration in US-China ties, the number of deals involving Chinese companies reviewed by CFIUS dropped from 60 in 2017 to 55 in 2018 and 25 last year." In eight cases, CFIUS "told the parties to the transactions that they could not identify a